Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fleur Hammet

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Breast Cancer Research and Treatment|June 6, 2007
Is BRCA2 c.9079 G>A a predisposing variant for early onset breast cancer?Fleur Hammet, Jessica George, Andrea A Tesoriero, et al.
Genetics Research|August 11, 2020
Genetic testing in Poland and Ukraine: should comprehensive germline testing of <i>BRCA1</i> and <i>BRCA2</i> be recommended for women with breast and ovarian cancer?Tu Nguyen-Dumont, Pawel Karpinski, Maria M Sasiadek, et al.
International Journal of Cancer|April 28, 2020
Rare germline genetic variants and risk of aggressive prostate cancerTú Nguyen-Dumont, Robert J MacInnis, Jason A Steen, et al.
Breast Cancer Research and Treatment|January 11, 2015
Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family RegistryTú Nguyen-Dumont, Fleur Hammet, Maryam Mahmoodi, et al.
BMC Cancer|February 10, 2018
Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?Tú Nguyen-Dumont, Zhi L Teo, Fleur Hammet, et al.
International Journal of Molecular Sciences|April 3, 2021
<i>VTRNA2-1</i>: Genetic Variation, Heritable Methylation and Disease AssociationPierre-Antoine Dugué, Chenglong Yu, Timothy McKay, et al.
Cancers|April 3, 2021
Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate CancerTú Nguyen-Dumont, James G Dowty, Robert J MacInnis, et al.
NPJ Breast Cancer|December 10, 2021
Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testingMelissa C Southey, James G Dowty, Moeen Riaz, et al.
Cancer Discovery|July 23, 2014
Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancersDaniel J Park, Kayoko Tao, Florence Le Calvez-Kelm, et al.
Plos One|July 7, 2012
Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2Tomas Kirchhoff, Mia M Gaudet, Antonis C Antoniou, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Breast Cancer Research and Treatment|June 6, 2007
Is BRCA2 c.9079 G>A a predisposing variant for early onset breast cancer?Fleur Hammet, Jessica George, Andrea A Tesoriero, et al.
Genetics Research|August 11, 2020
Genetic testing in Poland and Ukraine: should comprehensive germline testing of <i>BRCA1</i> and <i>BRCA2</i> be recommended for women with breast and ovarian cancer?Tu Nguyen-Dumont, Pawel Karpinski, Maria M Sasiadek, et al.
International Journal of Cancer|April 28, 2020
Rare germline genetic variants and risk of aggressive prostate cancerTú Nguyen-Dumont, Robert J MacInnis, Jason A Steen, et al.
Breast Cancer Research and Treatment|January 11, 2015
Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family RegistryTú Nguyen-Dumont, Fleur Hammet, Maryam Mahmoodi, et al.
BMC Cancer|February 10, 2018
Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?Tú Nguyen-Dumont, Zhi L Teo, Fleur Hammet, et al.
International Journal of Molecular Sciences|April 3, 2021
<i>VTRNA2-1</i>: Genetic Variation, Heritable Methylation and Disease AssociationPierre-Antoine Dugué, Chenglong Yu, Timothy McKay, et al.
Cancers|April 3, 2021
Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate CancerTú Nguyen-Dumont, James G Dowty, Robert J MacInnis, et al.
NPJ Breast Cancer|December 10, 2021
Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testingMelissa C Southey, James G Dowty, Moeen Riaz, et al.
Cancer Discovery|July 23, 2014
Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancersDaniel J Park, Kayoko Tao, Florence Le Calvez-Kelm, et al.
Plos One|July 7, 2012
Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2Tomas Kirchhoff, Mia M Gaudet, Antonis C Antoniou, et al.
Pageof 4